Literature DB >> 18259889

Knockdown of cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosis.

Musarat Ishaq1, Jiajie Hu, Xiaoyun Wu, Qiong Fu, Yalin Yang, Qingzhen Liu, Deyin Guo.   

Abstract

The targeting of a cellular co-factor, rather than the HIV-1-specific RNAs, by small interfering RNAs holds promise as the rapid mutational ability of the HIV-1 genome may obviate the potential clinical use of RNAi against this virus. The DEAD-box RNA helicase DDX3 is an essential Rev co-factor in the CRM1-Rev-RRE complex that promotes the export of unspliced and single-spliced HIV-1 RNAs from the nucleus to cytoplasm. In this report, human DDX3 was targeted by specific short hairpin RNAs, and the down-regulation of cell's endogenous DDX3 suppressed the nuclear export of unspliced HIV-1 RNAs but did not affect the cell viability. We further showed that the knockdown of cellular DDX3 could effectively inhibit the replication of HIV-1. Therefore, the current results suggest that the RNA helicase DDX3 may become a potential target by RNAi for future genetic therapy of HIV/AIDS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259889     DOI: 10.1007/s12033-008-9040-0

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  27 in total

1.  RNAi in human cells: basic structural and functional features of small interfering RNA.

Authors:  Ya-Lin Chiu; Tariq M Rana
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

2.  Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance.

Authors:  Joseph Anderson; Akhil Banerjea; Ramesh Akkina
Journal:  Oligonucleotides       Date:  2003

Review 3.  DEAD-box proteins: the driving forces behind RNA metabolism.

Authors:  Sanda Rocak; Patrick Linder
Journal:  Nat Rev Mol Cell Biol       Date:  2004-03       Impact factor: 94.444

4.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

6.  Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function.

Authors:  Venkat S R K Yedavalli; Christine Neuveut; Ya-Hui Chi; Lawrence Kleiman; Kuan-Teh Jeang
Journal:  Cell       Date:  2004-10-29       Impact factor: 41.582

7.  Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus.

Authors:  T J Hope; D McDonald; X J Huang; J Low; T G Parslow
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Specific inhibition of HIV-1 replication by short hairpin RNAs targeting human cyclin T1 without inducing apoptosis.

Authors:  Zhaoyang Li; Yong Xiong; Yu Peng; Ji'an Pan; Yu Chen; Xiaoyun Wu; Snawar Hussain; Po Tien; Deyin Guo
Journal:  FEBS Lett       Date:  2005-06-06       Impact factor: 4.124

Review 9.  Viral bioinformatics: computational views of host and pathogen.

Authors:  Paul Kellam; Ria Holzerlandt; Eva Gramoustianou; Richard Jenner; Antonia Kwan
Journal:  Novartis Found Symp       Date:  2003

10.  Association of RNA helicase a with human immunodeficiency virus type 1 particles.

Authors:  Bibhuti Bhusan Roy; Jing Hu; Xiaofeng Guo; Rodney S Russell; Fei Guo; Lawrence Kleiman; Chen Liang
Journal:  J Biol Chem       Date:  2006-03-08       Impact factor: 5.157

View more
  28 in total

Review 1.  The use of cell-delivered gene therapy for the treatment of HIV/AIDS.

Authors:  Geoff P Symonds; Helen A Johnstone; Michelle L Millington; Maureen P Boyd; Bryan P Burke; Louis R Breton
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 2.  Novel targets for antiretroviral therapy: clinical progress to date.

Authors:  Birgitt Dau; Mark Holodniy
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  A Survey of DDX21 Activity During Rev/RRE Complex Formation.

Authors:  John A Hammond; Li Zhou; Rajan Lamichhane; Hui-Yi Chu; David P Millar; Larry Gerace; James R Williamson
Journal:  J Mol Biol       Date:  2017-07-10       Impact factor: 5.469

4.  Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication.

Authors:  Venkat S R K Yedavalli; Ning Zhang; Hongyi Cai; Peng Zhang; Matthew F Starost; Ramachandra S Hosmane; Kuan-Teh Jeang
Journal:  J Med Chem       Date:  2008-08-05       Impact factor: 7.446

Review 5.  HIV-1 endocytosis in astrocytes: a kiss of death or survival of the fittest?

Authors:  Ashok Chauhan; Akshay Tikoo; Jankiben Patel; Arwa Mujahid Abdullah
Journal:  Neurosci Res       Date:  2014-09-08       Impact factor: 3.304

Review 6.  From promoting to inhibiting: diverse roles of helicases in HIV-1 Replication.

Authors:  Rene-Pierre Lorgeoux; Fei Guo; Chen Liang
Journal:  Retrovirology       Date:  2012-09-28       Impact factor: 4.602

Review 7.  RNA Helicase DDX3: A Double-Edged Sword for Viral Replication and Immune Signaling.

Authors:  Tomás Hernández-Díaz; Fernando Valiente-Echeverría; Ricardo Soto-Rifo
Journal:  Microorganisms       Date:  2021-06-03

8.  Virus-producing cells determine the host protein profiles of HIV-1 virion cores.

Authors:  Steven Santos; Yuri Obukhov; Sergei Nekhai; Michael Bukrinsky; Sergey Iordanskiy
Journal:  Retrovirology       Date:  2012-08-13       Impact factor: 4.602

9.  Human DDX3 interacts with the HIV-1 Tat protein to facilitate viral mRNA translation.

Authors:  Ming-Chih Lai; Shainn-Wei Wang; Lie Cheng; Woan-Yuh Tarn; Shaw-Jenq Tsai; H Sunny Sun
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

10.  Unbiased proteomic analysis of proteins interacting with the HIV-1 5'LTR sequence: role of the transcription factor Meis.

Authors:  A Tacheny; S Michel; M Dieu; L Payen; T Arnould; P Renard
Journal:  Nucleic Acids Res       Date:  2012-08-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.